nicotine has been researched along with Airflow Obstruction, Chronic in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 31 (39.24) | 29.6817 |
| 2010's | 37 (46.84) | 24.3611 |
| 2020's | 11 (13.92) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Chen, Y; Ding, Y; Mo, R; Zhang, J | 1 |
| Ehnert, S; Flesch, I; Histing, T; Ihle, C; Maurer, E; Nüssler, AK; Reumann, M; Schreiner, AJ; Stollhof, LE; Wallmeier, V | 1 |
| Bai, XX; Liao, YH; Liu, JP; Robinson, N; Tang, WT; Wang, J; Zhang, H; Zhang, YY | 1 |
| Alexis, NE; Barjaktarevic, I; Boucher, RC; Bowler, RP; Comellas, AP; Cooper, CB; Curtis, JL; Esther, CR; Halper-Stromberg, E; Hastie, AT; Koch, AL; O'Neal, WK; Ortega, VE; Peters, SP; Raffield, LM; Rennard, SI; Ronish, B; Wells, JM | 1 |
| Li, P; Li, X; Xu, J | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Bonassi, S; Giacconi, R; Maggi, F; Malavolta, M; Russo, P; Tomino, C | 1 |
| Leung, JM; Sin, DD; Yang, CX | 1 |
| Alexandris, N; Angelopoulou, A; Farsalinos, K; Poulas, K | 1 |
| Baker, TB; Bierut, LJ; Bray, MJ; Chen, LS; Culverhouse, RC; Fox, L; Hancock, DB; Hartz, SM; Hokanson, JE; Johnson, EO; Liu, M; McKay, JD; Saccone, NL; Tyndale, RF; Vrieze, SI | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| Bover Manderski, MT; Delnevo, CD; Singh, B; Steinberg, MB; Wackowski, OA; Young, WJ | 1 |
| Bodas, M; Vij, N | 1 |
| Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G | 1 |
| Chen, L; Dai, A; Jiang, Y; Li, C; Li, W; Liu, L; Pan, D; Peng, G; Ran, P; Tian, H; Yang, X; Zhou, Y | 1 |
| Campos, MA; Cartujano-Barrera, F; Córdoba-Lanús, E; Cupertino, P; Falfán-Valencia, R; Pérez-Rubio, G | 1 |
| Fischer, P; Gross, V; Hildebrandt, O; Hofmann, S; Koehler, U; Noeh, C; Schudt, F; Sohrabi, K | 1 |
| Schuller, HM | 1 |
| Tønnesen, P | 1 |
| Pearson, M | 1 |
| Sasaki, J | 1 |
| Abe, M | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Gomez, DR; Liao, Z; Wang, H | 1 |
| Daughton, DM; Rennard, SI | 1 |
| Dai, A; Hu, G; Jiang, Y; Li, B; Peng, G; Ran, P; Sham, JS; Zhou, Y | 1 |
| Jónsdóttir, H; Klinke, ME | 1 |
| Kamrath, P; Kreuz, J; Linhart, M; Lorenzen, H; Nickenig, G; Schwab, JO; Skowasch, D; Tiyerili, V | 1 |
| Jagpal, S; Mikhail, J; Pistun, O | 1 |
| Bourdin, A; Chanez, P; Gamez, AS; Gras, D; Knabe, L; Molinari, N; Petit, A; Vachier, I | 1 |
| Tashkin, DP | 1 |
| Behrsing, H; Bombick, B; Braun, A; Cao, X; Constant, S; Curren, R; D'Ruiz, C; Gaça, M; Hayden, P; Hill, E; Hoeng, J; Manuppello, J; Mathis, C; Phillips, G; Phipps, R; Raabe, H; Sethi, S; Sullivan, K; Tarran, R; Tesfaigzi, Y; Yan, S | 1 |
| Bodas, M; Carpenter-Thompson, R; K Mohanty, D; Van Westphal, C; Vij, N | 1 |
| Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC | 1 |
| Baumlin, N; Campos, M; Cummins, N; Dabo, AJ; Eden, E; Foronjy, R; Garcia-Arcos, I; Geraghty, P; Grosche, A; Jundi, B; Salathe, M | 1 |
| Larsson, K; Nathell, L; Sundblad, BM | 1 |
| Ebbert, JO; Hays, JT | 1 |
| Conti, V; De Marchis, L; Girardi, E; Paone, G; Principe, R; Puglisi, G; Schmid, G; Serpilli, M | 1 |
| Bredesen, H; Lous, J | 1 |
| Laniado-Laborín, R | 1 |
| Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K | 1 |
| Andreas, S; Hering, T; Mühlig, S; Nowak, D; Raupach, T; Worth, H | 1 |
| Górecka, D | 1 |
| Crystal, RG; Harvey, BG; Krause, A; O'Connor, TP; Salit, J; Shaykhiev, R; Strulovici-Barel, Y | 1 |
| Goodfellow, LT; Waugh, JB | 1 |
| Berlin, I | 1 |
| Dicpinigaitis, PV; Sitkauskiene, B | 1 |
| Patel, JD; Ramchandran, K | 1 |
| Quist-Paulsen, P | 1 |
| Kottom, TJ; Lamont, J; Limper, AH; Vassallo, R; Walters, PR; Yi, ES | 1 |
| Breteler, MH; de Vries, H; Grol, RP; Hilberink, SR; Jacobs, JE | 1 |
| Gross, NJ | 1 |
| Berlin, I; Coudert, M; Jacob, N; Perriot, J; Rodon, N; Schultz, L | 1 |
| Gross, H | 1 |
| Diaz, PT; Rahmanian, SD; Wewers, ME | 1 |
| He, J; Lin, YY; Ma, S; Robbins, RA; Slowik, N; Soldin, OP; Turino, GM | 1 |
| Caponnetto, P; Polosa, R; Russo, C | 1 |
| Fu, XW; Rekow, SS; Spindel, ER | 1 |
| Akkermans, R; Heijdra, Y; Klerx, W; Lenders, JW; Scheepers, PT; Schermer, TR; van der Pouw, A; van Dijk, WD; van Weel, C | 1 |
| Boezen, HM; De Jong, PA; Decramer, M; Groen, HJ; Janssens, W; Lambrechts, D; Lammers, JW; Mohamed Hoesein, FA; Postma, DS; Smolonska, J; Wauters, E; Wijmenga, C; Zanen, P | 1 |
| Ferrero, MB; Jiménez-Ruiz, C; Mezquita, MH; Solano, S; Torrecilla, M; Viteri, SA | 1 |
| van Schayck, CP; Wagena, EJ; Wouters, EF; Zeegers, MP | 1 |
| Aldrich, TK; Appel, DW | 1 |
| Kabat, GC | 1 |
| Kawane, H | 1 |
| Kino, H | 1 |
| Bednarek, M; Goljan-Geremek, A; Górecka, D; Nowiński, A; Puścińska, E; Zieliński, J | 1 |
| Bruggmann, P; Fritsch, K; Jacot, ML; Klarer, A; Krause, M; Thurnheer, R; Wick, F | 1 |
| Daae, HL; Ellingsen, DG; Fladseth, G; Gjølstad, M; Kjaerheim, K; Molander, P; Olsen, R; Skogstad, M | 1 |
| Aytemur Solak, Z; Başoğlu, OK; Erdinç, E | 1 |
| Britton, J; Currie, GP; Srivastava, P | 1 |
| Balmes, J; Benowitz, N; Blanc, PD; Eisner, MD; Hammond, SK; Katz, PP; Yelin, EH | 1 |
| Pbert, L | 1 |
| Bremann, L; Mikkelsen, K; Tønnesen, P | 1 |
| Clark, ML; Gideon, KM; Harbo, SJ; Johnson, RE; Lee, KM; Renne, RA | 1 |
| Brusselle, GG; Demedts, IK; Jeffery, PK; Tsoumakidou, M | 1 |
| Sopori, M | 1 |
| Chernesky, M; Chong, S; Goldsmith, CH; Hargreave, FE; Kamada, D; Leigh, R; Mahony, JB; Petrich, A; Smieja, M | 1 |
31 review(s) available for nicotine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
Topics: Animals; Autophagy; Evidence-Based Medicine; Humans; Lung; Male; Nicotiana; Nicotine; Prognosis; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Smoke; Smoking | 2017 |
ROLE OF GENETIC SUSCEPTIBILITY IN NICOTINE ADDICTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Topics: Disease Progression; Genetic Predisposition to Disease; Humans; Mexico; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tobacco Use Disorder | 2019 |
The impact of smoking and the influence of other factors on lung cancer.
Topics: Adenocarcinoma of Lung; Animals; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Nicotine; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Risk Factors; Signal Transduction; Small Cell Lung Carcinoma; Smoking | 2019 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
[Compounds in tobacco smoke and pathogenesis of the diseases].
Topics: Carbon Monoxide; DNA Damage; Heart Diseases; Humans; Japan; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking | 2013 |
[Problems of tobacco smoke and positive effects of quit-smoking on human health].
Topics: Humans; Japan; Nicotine; Public Health; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Tobacco Use Disorder | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Smoking addiction in chronic obstructive pulmonary disease: Integrating neurobiology and phenomenology through a review of the literature.
Topics: Behavior, Addictive; Brain; Humans; Neurobiology; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Tobacco Use Disorder | 2014 |
Smoking Cessation in Chronic Obstructive Pulmonary Disease.
Topics: Combined Modality Therapy; Counseling; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
Smoking cessation for people with chronic obstructive pulmonary disease.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2016 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
[Smoking cessation in patients with chronic obstructive pulmonary disease].
Topics: Health Education; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Social Support | 2009 |
Tobacco treatment and prevention: what works and why.
Topics: Central Nervous System Stimulants; Health Promotion; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Respiratory Therapy; Smoking Cessation; Social Control, Formal | 2009 |
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Humans; Nicotine; Nortriptyline; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2009 |
Effect of smoking on cough reflex sensitivity in humans.
Topics: Action Potentials; Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Cough; Guinea Pigs; Humans; Lung; Models, Animal; Nerve Fibers, Unmyelinated; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Reflex; Smoking; Substance P | 2010 |
Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients.
Topics: Coronary Disease; Cost-Benefit Analysis; Directive Counseling; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Time Factors | 2008 |
Tobacco use and cessation among women: research and treatment-related issues.
Topics: Causality; Disease Susceptibility; Female; Humans; Life Style; Lung Neoplasms; Male; Nicotine; Prevalence; Pulmonary Disease, Chronic Obstructive; Risk Factors; Sex Distribution; Sex Factors; Smoking; Smoking Cessation | 2011 |
Smoking cessation: present status and future perspectives.
Topics: Animals; Behavior Therapy; Drugs, Investigational; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Vaccines | 2012 |
Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
Topics: Administration, Buccal; Administration, Intranasal; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Smoking Cessation; Tobacco Use Disorder | 2003 |
Smoking cessation in the elderly.
Topics: Administration, Cutaneous; Aged; Behavior Therapy; Clonidine; Counseling; Habits; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Fifty years' experience of reduced-tar cigarettes: what do we know about their health effects?
Topics: Coronary Disease; Epidemiologic Studies; Humans; Lung Neoplasms; Nicotiana; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Smoking; Tars; United States | 2003 |
[Prevention of chronic obstructive pulmonary disease (primary prevention and secondary prevention)].
Topics: Adolescent; Behavior Therapy; Disease Progression; Health Education; Humans; Nicotine; Primary Prevention; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Smoke Pollution; Tobacco Use Disorder | 2003 |
[New drug therapy of chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Antidepressive Agents; Antioxidants; Bronchodilator Agents; Bupropion; Cholinergic Antagonists; Disease Progression; Drug Design; Humans; Nicotine; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Theophylline | 2003 |
Smoking cessation.
Topics: Behavior Therapy; Counseling; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Social Support | 2006 |
Dendritic cells in chronic obstructive pulmonary disease: new players in an old game.
Topics: Antigens, CD; Dendritic Cells; Ganglionic Stimulants; Humans; Nicotiana; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking | 2008 |
Effects of cigarette smoke on the immune system.
Topics: Adolescent; Animals; Female; Humans; Immunity; Immunity, Cellular; Immunity, Innate; Immunosuppressive Agents; Male; Models, Immunological; Neuroimmunomodulation; Neuroprotective Agents; Nicotiana; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking | 2002 |
7 trial(s) available for nicotine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Persistent Misperceptions about Nicotine among US Physicians: Results from a Randomized Survey Experiment.
Topics: Female; Humans; Nicotine; Physicians, Family; Prevalence; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires | 2021 |
General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions.
Topics: Adult; Aged; Attitude to Health; Counseling; Female; General Practice; General Practitioners; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Prevalence; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Time Factors | 2011 |
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
Topics: Administration, Buccal; Cardiovascular Diseases; Comorbidity; Cotinine; Counseling; Diabetes Mellitus; Female; France; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Recurrence; Saliva; Smoking; Smoking Cessation; Socioeconomic Factors; Statistics as Topic; Transdermal Patch | 2011 |
Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; Tars; Vital Capacity | 2013 |
[Effect of treatment for nicotine dependence in patients with COPD].
Topics: Administration, Cutaneous; Adult; Aged; Attitude to Health; Bupropion; Delayed-Action Preparations; Disease Progression; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Poland; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.
Topics: Administration, Sublingual; Behavior Control; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2006 |
42 other study(ies) available for nicotine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Nicotine promotes chronic obstructive pulmonary disease via inducing pyroptosis activation in bronchial epithelial cells.
Topics: Apoptosis; Blotting, Western; Bronchi; Caspase 1; Cell Line; Cell Proliferation; Epithelial Cells; Ganglionic Stimulants; Gene Expression; Humans; Interleukin-18; Interleukin-1beta; Microscopy, Fluorescence; Nicotine; Pulmonary Disease, Chronic Obstructive; Pyroptosis; Reverse Transcriptase Polymerase Chain Reaction | 2022 |
Increased Age, Cardiovascular Comorbidities, COPD, and Diabetes mellitus Determine Excess Mortality in Trauma Patients with SSI or Chronic Wounds.
Topics: Aged, 80 and over; Diabetes Mellitus; Humans; Middle Aged; Nicotine; Peripheral Arterial Disease; Pulmonary Disease, Chronic Obstructive; Risk Factors; Surgical Wound Infection | 2023 |
Barriers and Facilitators for Smoking Cessation in Chinese Smokers with Chronic Obstructive Pulmonary Disease: A Qualitative Study.
Topics: Humans; Motivation; Nicotine; Pulmonary Disease, Chronic Obstructive; Recurrence; Smokers; Smoking Cessation | 2022 |
Prolonged, physiologically relevant nicotine concentrations in the airways of smokers.
Topics: Biomarkers; Cotinine; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Respiratory System; Smokers | 2023 |
Rat bone mesenchymal stem cells exert antiproliferative effects on nicotine‑exposed T cells via iNOS production.
Topics: Animals; Bone Marrow Cells; Cell Proliferation; Coculture Techniques; Disease Models, Animal; Gene Knockdown Techniques; Lentivirus; Male; Mesenchymal Stem Cells; Nicotine; Nitric Oxide Synthase Type II; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; T-Lymphocytes | 2020 |
COVID-19 and smoking: is nicotine the hidden link?
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Nicotine; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Smokers; Smoking | 2020 |
COVID-19 and nicotine as a mediator of ACE-2.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Nicotine; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Smokers | 2020 |
COVID-19 and the nicotinic cholinergic system.
Topics: Betacoronavirus; Cholinergic Agents; Coronavirus Infections; COVID-19; Humans; Nicotine; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Smokers | 2020 |
Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Topics: Alleles; Cytochrome P-450 CYP2A6; Genome-Wide Association Study; Humans; Linkage Disequilibrium; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Nicotine; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation | 2020 |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2017 |
TRPC channels mediated calcium entry is required for proliferation of human airway smooth muscle cells induced by nicotine-nAChR.
Topics: Aged; Calcium; Calcium Signaling; Cell Proliferation; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nicotine; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Respiratory System; TRPC Cation Channels | 2019 |
[The Nocturnal Respiratory Rate in COPD Patients of Varying GOLD Severity with/without Nicotine Consumption: Calculation by Means of Breath Sound Analysis].
Topics: Humans; Nicotine; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Severity of Illness Index | 2019 |
Is the primary mechanism underlying COPD: inflammation or ischaemia?
Topics: Bronchioles; Disease Progression; Humans; Inflammation; Ischemia; Nicotine; Occupational Exposure; Particulate Matter; Pulmonary Disease, Chronic Obstructive; Smoking; Vasoconstriction | 2013 |
β-Blockers and metastasis in non-small-cell lung cancer.
Topics: Adrenergic beta-Antagonists; Animals; Carcinoma, Non-Small-Cell Lung; gamma-Aminobutyric Acid; Humans; Lung Neoplasms; Neoplasms; Nicotine; Propranolol; Protective Agents; Pulmonary Disease, Chronic Obstructive; Stress, Psychological | 2013 |
Nicotine elevated intracellular Ca²⁺ in rat airway smooth muscle cells via activating and up-regulating α7-nicotinic acetylcholine receptor.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Calcium; Calcium Signaling; Lung; Male; Myocytes, Smooth Muscle; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Smoking; Up-Regulation | 2014 |
Influence of smoking dosage and chronic obstructive lung disease on the incidence of appropriate therapies and mortality in patients with structural heart disease and an implantable cardioverter defibrillator.
Topics: Aged; Coronary Artery Disease; Defibrillators, Implantable; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Male; Nicotine; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Smoking | 2015 |
Pirfenidone for idiopathic pulmonary fibrosis, thrombocytosis in chronic obstructive pulmonary disease exacerbations, and a longitudinal study on e-cigarettes.
Topics: Antifibrinolytic Agents; Aspirin; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Nicotine; Platelet Aggregation Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Smoking; Smoking Cessation; Thrombocytosis; Ticlopidine; Tobacco Use Cessation Devices | 2014 |
Supplementing defect in club cell secretory protein attenuates airway inflammation in COPD.
Topics: Adult; Aged; Case-Control Studies; Cells, Cultured; Epithelial Cells; Female; Humans; In Vitro Techniques; Interleukin-8; Male; Middle Aged; Nicotine; Pneumonia; Pulmonary Disease, Chronic Obstructive; Recombinant Proteins; Smoking; Uteroglobin | 2015 |
Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use.
Topics: Animal Experimentation; Animals; Goblet Cells; Government Regulation; Humans; Mucociliary Clearance; Mucus; Nicotine; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Tobacco Products; United States; United States Food and Drug Administration | 2016 |
Nicotine exposure induces bronchial epithelial cell apoptosis and senescence via ROS mediated autophagy-impairment.
Topics: Animals; Apoptosis; Autophagy; Bronchi; Cell Line; Cellular Senescence; Cysteamine; Cystine Depleting Agents; Epithelial Cells; Lung; Mice, Inbred C57BL; Nicotine; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Water Pipe Smoking | 2016 |
Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner.
Topics: Administration, Inhalation; Adult; Animals; Apoptosis; Bronchi; Cells, Cultured; Cilia; Cytokines; Electronic Nicotine Delivery Systems; Epithelial Cells; Female; Humans; Lung; Male; Methacholine Chloride; Mice, Inbred A; Middle Aged; Mucins; Nicotine; Peptide Hydrolases; Pulmonary Disease, Chronic Obstructive; Tobacco Use Disorder | 2016 |
High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Follow-Up Studies; Ganglionic Stimulants; Hospitalization; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2008 |
The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Follow-Up Studies; Humans; Middle Aged; Nicotine; Prognosis; Pulmonary Disease, Chronic Obstructive; Rehabilitation Centers; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
[Smoking cessation with special focus on primary health care].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascular Diseases; Counseling; Evidence-Based Medicine; Family Practice; Humans; Nicotine; Nortriptyline; Outcome Assessment, Health Care; Primary Health Care; Psychotherapy, Group; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention | 2009 |
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult | 2009 |
Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.
Topics: Counseling; Germany; Health Promotion; Humans; Nicotine; Psychology; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 2009 |
Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cell Polarity; Female; Gene Expression Regulation; Humans; Inflammation Mediators; Lung; Macrophages, Alveolar; Male; Middle Aged; Nicotine; Oligonucleotide Array Sequence Analysis; Pulmonary Disease, Chronic Obstructive; Smoking | 2009 |
Sex differences in susceptibility to carcinogens.
Topics: Carcinogens; Cytochrome P-450 Enzyme System; Disease Susceptibility; DNA Adducts; DNA Repair; Estrogens; Female; Humans; Lung; Lung Neoplasms; Male; Nicotine; Pulmonary Disease, Chronic Obstructive; Receptors, Estrogen; Risk Factors; Sex Factors | 2009 |
Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study.
Topics: Aged; Animals; Antigens, CD; Antigens, CD1; bcl-X Protein; Case-Control Studies; CD83 Antigen; Cell Survival; Cells, Cultured; Chemokine CCL21; Chemotaxis; Dendritic Cells; Dose-Response Relationship, Drug; Female; Heme Oxygenase-1; Humans; Immunoglobulins; Langerhans Cells; Lectins, C-Type; Lung; Male; Mannose-Binding Lectins; Membrane Glycoproteins; Mice; Middle Aged; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Receptors, CCR7; RNA, Messenger; Smoke; Smoking; Time Factors | 2010 |
The COPD pipeline VII.
Topics: Animals; Biotechnology; Clinical Trials as Topic; Genotype; Humans; Industry; Isotretinoin; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Smoking Cessation; Stilbenes | 2010 |
[Tobacco smoking cessation as covered cost for COPD patients? Therapy goal: smoking cessation without relapse].
Topics: General Practice; Germany; Humans; Insurance Coverage; National Health Programs; Nicotine; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Social Support | 2010 |
The effect of secondhand smoke exposure on markers of elastin degradation.
Topics: Adult; Aged; Biomarkers; Cohort Studies; Cotinine; Desmosine; Elastin; Female; Humans; Isodesmosine; Male; Middle Aged; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tobacco Smoke Pollution; Young Adult | 2011 |
The ly-6 protein, lynx1, is an endogenous inhibitor of nicotinic signaling in airway epithelium.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antigens, Ly; Asthma; Bronchi; Cells, Cultured; Gene Knockdown Techniques; GPI-Linked Proteins; Macaca mulatta; Mucin 5AC; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Receptors, GABA-A; Receptors, Nicotinic; Respiratory Mucosa; RNA, Small Interfering; Signal Transduction; Smoking; src-Family Kinases | 2012 |
Variants in the 15q24/25 locus associate with lung function decline in active smokers.
Topics: Aged; Chromosomes, Human, Pair 15; Female; Forced Expiratory Flow Rates; Genetic Loci; Genetic Variation; Humans; Lung; Male; Middle Aged; Nicotine; Protein Subunits; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Smoking; Substance-Related Disorders | 2013 |
Harm reduction--a treatment approach for resistant smokers with tobacco-related symptoms.
Topics: Adult; Aged; Chewing Gum; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Time Factors; Tobacco Use Disorder | 2002 |
Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.
Topics: Adrenal Cortex Hormones; Aged; Bronchodilator Agents; Drug Utilization; Female; Guideline Adherence; Hospitals, Teaching; Humans; Male; Nicotine; Nicotinic Agonists; Oxygen Inhalation Therapy; Patient Education as Topic; Pneumonectomy; Practice Guidelines as Topic; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Smoking; Smoking Cessation; Surveys and Questionnaires; Switzerland | 2005 |
Cross shift changes in lung function among bar and restaurant workers before and after implementation of a smoking ban.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Norway; Occupational Diseases; Occupational Exposure; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Restaurants; Smoking; Tobacco Smoke Pollution | 2006 |
[Success of smoking cessation in patients with chronic obstructive pulmonary disease].
Topics: Bupropion; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Turkey | 2006 |
Directly measured secondhand smoke exposure and COPD health outcomes.
Topics: Aged; Cotinine; Dyspnea; Female; Film Dosimetry; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Risk Factors; Severity of Illness Index; Tobacco Smoke Pollution | 2006 |
Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support.
Topics: Administration, Sublingual; Behavior Control; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice.
Topics: Aerosols; Animals; Apoptosis; Biomarkers; Body Weight; Bronchoalveolar Lavage Fluid; Carboxyhemoglobin; Cotinine; Cytokines; Disease Models, Animal; Feasibility Studies; Inhalation Exposure; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred AKR; Neutrophils; Nicotiana; Nicotine; Particle Size; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Respiratory System; Smoke; Time Factors | 2007 |
Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients.
Topics: Aged; Antibodies, Bacterial; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; DNA, Bacterial; Female; Humans; Male; Nicotine; Pulmonary Disease, Chronic Obstructive; Seasons; Sex Factors; Smoking; Sputum | 2002 |